In Nature this week: synthetic Escherichia coli genome with fewer codons, and more.
During the second quarter of fiscal 2019, the firm took orders for genes, libraries, and oligonucleotide pools from about 780 customers.
The Economist explores potential uses of synthetic biology to alter what proteins are produced.
In Science this week: the synthetic genetic system hachimoji, and more.
Ohio State University researchers found that a phosphorothioate-modified DNA-crRNA duplex completely blocked the function of Cas12a.
Agilent alleges that Twist CEO Emily Leproust and other employees stole trade secrets from it. A trial date has been set for Feb. 24, 2020.
The Intelligence Advanced Research Projects Activity has amassed a team to spot DNA orders that could be used in bioweapons, Bloomberg reports.
The Genome Project–write leaders propose the development of virus-resistant cells, according to Science.
ExxonMobil and Synthetic Genomics are moving forward with their exploration of algae-based biofuels, the San Diego Union-Tribune reports.
The computational tools will be designed to screen DNA sequences to detect biological threats that may arise from synthetic microbial manipulation.
New US Department of Commerce rules will affect supercomputing in China, according to the Wall Street Journal.
A new analysis finds that it will be more than a century until female computer scientists publish at the same rate as their male counterparts, ScienceInsider reports.
Broad Institute researchers describe an approach they've dubbed "DNA microscopy."
In PLOS this week: epigenetic changes following hepatitis C virus treatment, metagenomic analysis of Ugandan children with febrile illness, and more.
